Recent Advances on Extracellular Vesicles in Central Nervous System Diseases

References

• Thery C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.30637094
   PubMed Web of Science ®Google Scholar
• Yang D, Zhang W, Zhang H, et al. Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics. Theranostics. 2020;10(8):3684–3707. doi:10.7150/thno.4158032206116
   PubMed Web of Science ®Google Scholar
• Sims B, Gu L, Krendelchtchikov A, Matthews QL. Neural stem cell-derived exosomes mediate viral entry. Int J Nanomedicine. 2014;9:4893–4897. doi:10.2147/IJN.S7099925364247
   PubMed Web of Science ®Google Scholar
• Faure J, Lachenal G, Court M, et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci. 2006;31(4):642–648. doi:10.1016/j.mcn.2005.12.00316446100
   PubMed Web of Science ®Google Scholar
• Sharma P, Schiapparelli L, Cline HT. Exosomes function in cell-cell communication during brain circuit development. Curr Opin Neurobiol. 2013;23(6):997–1004. doi:10.1016/j.conb.2013.08.00523998929
   PubMed Web of Science ®Google Scholar
• Kalra H, Simpson RJ, Ji H, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012;10(12):e1001450. doi:10.1371/journal.pbio.100145023271954
   PubMed Web of Science ®Google Scholar
• Bergsmedh A, Szeles A, Henriksson M, et al. Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Natl Acad Sci U S A. 2001;98(11):6407–6411. doi:10.1073/pnas.10112999811353826
   PubMed Web of Science ®Google Scholar
• Gregory CD, Dransfield I. Apoptotic tumor cell-derived extracellular vesicles as important regulators of the onco-regenerative niche. Front Immunol. 2018;9:1111. doi:10.3389/fimmu.2018.0111129875772
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. doi:10.1126/science.aau697732029601
   PubMed Web of Science ®Google Scholar
• Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183(3):1161–1172. doi:10.1084/jem.183.3.11618642258
   PubMed Web of Science ®Google Scholar
• Wolfers J, Lozier A, Raposo G, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001;7(3):297–303. doi:10.1038/8543811231627
   PubMed Web of Science ®Google Scholar
• Hurley JH. ESCRTs are everywhere. EMBO J. 2015;34(19):2398–2407. doi:10.15252/embj.20159248426311197
   PubMed Web of Science ®Google Scholar
• Zhen Y, Stenmark H. Cellular functions of Rab GTPases at a glance. J Cell Sci. 2015;128(17):3171–3176. doi:10.1242/jcs.16607426272922
   PubMed Web of Science ®Google Scholar
• Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19–30. doi:10.1038/ncb200019966785
   PubMed Web of Science ®Google Scholar
• Gross JC, Chaudhary V, Bartscherer K, Boutros M. Active Wnt proteins are secreted on exosomes. Nat Cell Biol. 2012;14(10):1036–1045. doi:10.1038/ncb257422983114
   PubMed Web of Science ®Google Scholar
• Verweij FJ, Bebelman MP, Jimenez CR, et al. Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling. J Cell Biol. 2018;217(3):1129–1142. doi:10.1083/jcb.20170320629339438
   PubMed Web of Science ®Google Scholar
• Sedgwick AE, D’Souza-Schorey C. The biology of extracellular microvesicles. Traffic. 2018;19(5):319–327. doi:10.1111/tra.1255829479795
   PubMed Web of Science ®Google Scholar
• Granger E, McNee G, Allan V, Woodman P. The role of the cytoskeleton and molecular motors in endosomal dynamics. Semin Cell Dev Biol. 2014;31:20–29. doi:10.1016/j.semcdb.2014.04.01124727350
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659. doi:10.1038/ncb159617486113
   PubMed Web of Science ®Google Scholar
• Ratajczak J, Miekus K, Kucia M, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006;20(5):847–856. doi:10.1038/sj.leu.240413216453000
   PubMed Web of Science ®Google Scholar
• Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10(12):1470–1476. doi:10.1038/ncb180019011622
   PubMed Web of Science ®Google Scholar
• Tkach M, Kowal J, Zucchetti AE, et al. Qualitative differences in T-cell activation by dendritic cell-derived extracellular vesicle subtypes. EMBO J. 2017;36(20):3012–3028. doi:10.15252/embj.20169600328923825
   PubMed Web of Science ®Google Scholar
• Cossetti C, Iraci N, Mercer TR, et al. Extracellular vesicles from neural stem cells transfer IFN-gamma via Ifngr1 to activate Stat1 signaling in target cells. Mol Cell. 2014;56(2):193–204. doi:10.1016/j.molcel.2014.08.02025242146
   PubMed Web of Science ®Google Scholar
• Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014;14(3):195–208. doi:10.1038/nri362224566916
   PubMed Web of Science ®Google Scholar
• Stefanius K, Servage K, de Souza Santos M, et al. Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformation. Elife. 2019;8:e40226. doi:10.7554/eLife.4022631134894
   PubMed Web of Science ®Google Scholar
• Le MT, Hamar P, Guo C, et al. miR-200-containing extracellular vesicles promote breast cancer cell metastasis. J Clin Invest. 2014;124(12):5109–5128. doi:10.1172/JCI7569525401471
   PubMed Web of Science ®Google Scholar
• Zhou W, Fong MY, Min Y, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014;25(4):501–515. doi:10.1016/j.ccr.2014.03.00724735924
   PubMed Web of Science ®Google Scholar
• Ricklefs FL, Alayo Q, Krenzlin H, et al. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. Sci Adv. 2018;4(3):eaar2766. doi:10.1126/sciadv.aar276629532035
   PubMed Web of Science ®Google Scholar
• Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int. 2018;2018:8545347. doi:10.1155/2018/854534729662902
   PubMed Web of Science ®Google Scholar
• Onodi Z, Pelyhe C, Terezia Nagy C, et al. Isolation of high-purity extracellular vesicles by the combination of iodixanol density gradient ultracentrifugation and bind-elute chromatography from blood plasma. Front Physiol. 2018;9:1479. doi:10.3389/fphys.2018.0147930405435
   PubMed Web of Science ®Google Scholar
• He L, Zhu D, Wang J, Wu X. A highly efficient method for isolating urinary exosomes. Int J Mol Med. 2019;43(1):83–90. doi:10.3892/ijmm.2018.394430365060
   PubMed Web of Science ®Google Scholar
• Patel GK, Khan MA, Zubair H, et al. Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications. Sci Rep. 2019;9(1):5335. doi:10.1038/s41598-019-41800-230926864
   PubMed Web of Science ®Google Scholar
• Taylor DD, Shah S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods. 2015;87:3–10. doi:10.1016/j.ymeth.2015.02.01925766927
   PubMed Web of Science ®Google Scholar
• Gyorgy B, Modos K, Pallinger E, et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood. 2011;117(4):e39–e48. doi:10.1182/blood-2010-09-30759521041717
   PubMed Web of Science ®Google Scholar
• Dragovic RA, Gardiner C, Brooks AS, et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine. 2011;7(6):780–788. doi:10.1016/j.nano.2011.04.00321601655
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Balaj L, Alian S, et al. Alternative methods for characterization of extracellular vesicles. Front Physiol. 2012;3:354. doi:10.3389/fphys.2012.0035422973237
   PubMed Web of Science ®Google Scholar
• Jarroux J, Morillon A, Pinskaya M. History, discovery, and classification of lncRNAs. Adv Exp Med Biol. 2017;1008:1–46.28815535
   PubMed Web of Science ®Google Scholar
• Conigliaro A, Costa V, Lo Dico A, et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol Cancer. 2015;14:155. doi:10.1186/s12943-015-0426-x26272696
   PubMed Web of Science ®Google Scholar
• Liu Y, Zou R, Wang Z, Wen C, Zhang F, Lin F. Exosomal KLF3-AS1 from hMSCs promoted cartilage repair and chondrocyte proliferation in osteoarthritis. Biochem J. 2018;475(22):3629–3638. doi:10.1042/BCJ2018067530341166
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981–984. doi:10.1038/cr.2015.8226138677
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu J, Ma J, et al. Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer. 2019;18(1):116. doi:10.1186/s12943-019-1041-z31277663
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang S, Wang H, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer. 2019;18(1):20. doi:10.1186/s12943-018-0935-530717751
   PubMed Web of Science ®Google Scholar
• Qian L, Yu S, Chen Z, Meng Z, Huang S, Wang P. The emerging role of circRNAs and their clinical significance in human cancers. Biochim Biophys Acta Rev Cancer. 2018;1870(2):247–260. doi:10.1016/j.bbcan.2018.06.00229928954
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhu L, Bai M, et al. Exosomal circRNA derived from gastric tumor promotes white adipose browning by targeting the miR-133/PRDM16 pathway. Int J Cancer. 2019;144(10):2501–2515. doi:10.1002/ijc.3197730412280
   PubMed Web of Science ®Google Scholar
• Tian L, Cao J, Jiao H, et al. CircRASSF2 promotes laryngeal squamous cell carcinoma progression by regulating the miR-302b-3p/IGF-1R axis. Clin Sci (Lond). 2019;133(9):1053–1066. doi:10.1042/CS2019011030992382
   PubMed Web of Science ®Google Scholar
• Li Z, Yanfang W, Li J, et al. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer. Cancer Lett. 2018;432:237–250. doi:10.1016/j.canlet.2018.04.03529709702
   PubMed Web of Science ®Google Scholar
• Li L, Li W, Chen N, et al. FLI1 exonic circular RNAs as a novel oncogenic driver to promote tumor metastasis in small cell lung cancer. Clin Cancer Res. 2019;25(4):1302–1317. doi:10.1158/1078-0432.CCR-18-144730429198
   PubMed Web of Science ®Google Scholar
• Batiz LF, Castro MA, Burgos PV, et al. Exosomes as novel regulators of adult neurogenic niches. Front Cell Neurosci. 2015;9:501. doi:10.3389/fncel.2015.0050126834560
   PubMed Web of Science ®Google Scholar
• Zhao C, Sun G, Li S, Shi Y. A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat Struct Mol Biol. 2009;16(4):365–371. doi:10.1038/nsmb.157619330006
   PubMed Web of Science ®Google Scholar
• Zhao C, Sun G, Li S, et al. MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX signaling. Proc Natl Acad Sci U S A. 2010;107(5):1876–1881. doi:10.1073/pnas.090875010720133835
   PubMed Web of Science ®Google Scholar
• Sharma P, Mesci P, Carromeu C, et al. Exosomes regulate neurogenesis and circuit assembly. Proc Natl Acad Sci U S A. 2019;116(32):16086–16094. doi:10.1073/pnas.190251311631320591
   PubMed Web of Science ®Google Scholar
• Holm MM, Kaiser J, Schwab ME. Extracellular vesicles: multimodal envoys in neural maintenance and repair. Trends Neurosci. 2018;41(6):360–372. doi:10.1016/j.tins.2018.03.00629605090
   PubMed Web of Science ®Google Scholar
• Mateos-Aparicio P, Rodriguez-Moreno A. Calcium dynamics and synaptic plasticity. Adv Exp Med Biol. 2020;1131(965–984).
   Web of Science ®Google Scholar
• Lachenal G, Pernet-Gallay K, Chivet M, et al. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci. 2011;46(2):409–418. doi:10.1016/j.mcn.2010.11.00421111824
   PubMed Web of Science ®Google Scholar
• Chivet M, Javalet C, Hemming F, et al. Exosomes as a novel way of interneuronal communication. Biochem Soc Trans. 2013;41(1):241–244. doi:10.1042/BST2012026623356290
   PubMed Web of Science ®Google Scholar
• Korkut C, Ataman B, Ramachandran P, et al. Trans-synaptic transmission of vesicular Wnt signals through Evi/Wntless. Cell. 2009;139(2):393–404. doi:10.1016/j.cell.2009.07.05119837038
   PubMed Web of Science ®Google Scholar
• Koles K, Nunnari J, Korkut C, et al. Mechanism of evenness interrupted (Evi)-exosome release at synaptic boutons. J Biol Chem. 2012;287(20):16820–16834. doi:10.1074/jbc.M112.34266722437826
   PubMed Web of Science ®Google Scholar
• Ashley J, Cordy B, Lucia D, Fradkin LG, Budnik V, Thomson T. Retrovirus-like Gag protein Arc1 binds RNA and traffics across synaptic boutons. Cell. 2018;172(1–2):262–274 e211. doi:10.1016/j.cell.2017.12.02229328915
   PubMed Web of Science ®Google Scholar
• Bahrini I, Song JH, Diez D, Hanayama R. Neuronal exosomes facilitate synaptic pruning by up-regulating complement factors in microglia. Sci Rep. 2015;5:7989. doi:10.1038/srep0798925612542
   PubMed Web of Science ®Google Scholar
• Falker C, Hartmann A, Guett I, et al. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity. J Neurochem. 2016;137(1):88–100. doi:10.1111/jnc.1351426710111
   PubMed Web of Science ®Google Scholar
• Yuyama K, Sun H, Usuki S, et al. A potential function for neuronal exosomes: sequestering intracerebral amyloid-beta peptide. FEBS Lett. 2015;589(1):84–88. doi:10.1016/j.febslet.2014.11.02725436414
   PubMed Web of Science ®Google Scholar
• Asai H, Ikezu S, Tsunoda S, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18(11):1584–1593. doi:10.1038/nn.413226436904
   PubMed Web of Science ®Google Scholar
• Stuendl A, Kunadt M, Kruse N, et al. Induction of alpha-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies. Brain. 2016;139(2):481–494. doi:10.1093/brain/awv34626647156
   PubMed Web of Science ®Google Scholar
• Basso M, Pozzi S, Tortarolo M, et al. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem. 2013;288(22):15699–15711. doi:10.1074/jbc.M112.42506623592792
   PubMed Web of Science ®Google Scholar
• Iguchi Y, Eid L, Parent M, et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 2016;139(12):3187–3201. doi:10.1093/brain/aww23727679482
   PubMed Web of Science ®Google Scholar
• Niu M, Li Y, Li G, et al. A longitudinal study on alpha-synuclein in plasma neuronal exosomes as a biomarker for Parkinson’s disease development and progression. Eur J Neurol. 2020;27(6):967–974. doi:10.1111/ene.1420832150777
   PubMed Web of Science ®Google Scholar
• Zhao ZH, Chen ZT, Zhou RL, Zhang X, Ye QY, Wang YZ. Increased DJ-1 and alpha-synuclein in plasma neural-derived exosomes as potential markers for parkinson’s disease. Front Aging Neurosci. 2018;10:438. doi:10.3389/fnagi.2018.0043830692923
   PubMed Web of Science ®Google Scholar
• Jiang C, Hopfner F, Katsikoudi A, et al. Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry. 2020;91(7):720–729. doi:10.1136/jnnp-2019-32258832273329
   PubMed Web of Science ®Google Scholar
• Cao Z, Wu Y, Liu G, et al. alpha-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson’s disease. Neurosci Lett. 2019;696:114–120. doi:10.1016/j.neulet.2018.12.03030579996
   PubMed Web of Science ®Google Scholar
• Si X, Tian J, Chen Y, Yan Y, Pu J, Zhang B. Central nervous system-derived exosomal alpha-synuclein in serum may be a biomarker in parkinson’s disease. Neuroscience. 2019;413:308–316. doi:10.1016/j.neuroscience.2019.05.01531102760
   PubMed Web of Science ®Google Scholar
• Shi M, Liu C, Cook TJ, et al. Plasma exosomal alpha-synuclein is likely CNS-derived and increased in Parkinson’s disease. Acta Neuropathol. 2014;128(5):639–650. doi:10.1007/s00401-014-1314-y24997849
   PubMed Web of Science ®Google Scholar
• Fraser KB, Rawlins AB, Clark RG, et al. Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson’s disease. Mov Disord. 2016;31(10):1543–1550. doi:10.1002/mds.2668627297049
   PubMed Web of Science ®Google Scholar
• Gui Y, Liu H, Zhang L, Lv W, Hu X. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget. 2015;6(35):37043–37053. doi:10.18632/oncotarget.615826497684
   PubMedGoogle Scholar
• Wang Q, Han CL, Wang KL, et al. Integrated analysis of exosomal lncRNA and mRNA expression profiles reveals the involvement of lnc-MKRN2-42:1 in the pathogenesis of Parkinson’s disease. CNS Neurosci Ther. 2020;26(5):527–537.31814304
   PubMed Web of Science ®Google Scholar
• Mendes-Pinheiro B, Anjo SI, Manadas B, et al. Bone marrow mesenchymal stem cells’ secretome exerts neuroprotective effects in a parkinson’s disease rat model. Front Bioeng Biotechnol. 2019;7:294.31737616
   PubMed Web of Science ®Google Scholar
• Chen HX, Liang FC, Gu P, et al. Exosomes derived from mesenchymal stem cells repair a Parkinson’s disease model by inducing autophagy. Cell Death Dis. 2020;11(4):288. doi:10.1038/s41419-020-2473-532341347
   PubMed Web of Science ®Google Scholar
• Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015;207:18–30. doi:10.1016/j.jconrel.2015.03.03325836593
   PubMed Web of Science ®Google Scholar
• Kojima R, Bojar D, Rizzi G, et al. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment. Nat Commun. 2018;9(1):1305. doi:10.1038/s41467-018-03733-829610454
   PubMed Web of Science ®Google Scholar
• Cooper JM, Wiklander PB, Nordin JZ, et al. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord. 2014;29(12):1476–1485. doi:10.1002/mds.2597825112864
   PubMed Web of Science ®Google Scholar
• Izco M, Blesa J, Schleef M, et al. Systemic exosomal delivery of shRNA minicircles prevents parkinsonian pathology. Mol Ther. 2019;27(12):2111–2122. doi:10.1016/j.ymthe.2019.08.01031501034
   PubMed Web of Science ®Google Scholar
• Qu M, Lin Q, Huang L, et al. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson’s disease. J Control Release. 2018;287:156–166. doi:10.1016/j.jconrel.2018.08.03530165139
   PubMed Web of Science ®Google Scholar
• Sun R, Wang H, Shi Y, Sun Z, Jiang H, Zhang J. Changes in the morphology, number, and pathological protein levels of plasma exosomes may help diagnose alzheimer’s disease. J Alzheimers Dis. 2020;73(3):909–917. doi:10.3233/JAD-19049731884461
   PubMed Web of Science ®Google Scholar
• Nam E, Lee YB, Moon C, Chang KA. Serum tau proteins as potential biomarkers for the assessment of alzheimer’s disease progression. Int J Mol Sci. 2020;21(14):5007. doi:10.3390/ijms21145007
   Web of Science ®Google Scholar
• Hamlett ED, Goetzl EJ, Ledreux A, et al. Neuronal exosomes reveal Alzheimer’s disease biomarkers in Down syndrome. Alzheimers Dement. 2017;13(5):541–549. doi:10.1016/j.jalz.2016.08.01227755974
   PubMed Web of Science ®Google Scholar
• Hamlett ED, LaRosa A, Mufson EJ, Fortea J, Ledreux A, Granholm AC. Exosome release and cargo in Down syndrome. Dev Neurobiol. 2019;79(7):639–655. doi:10.1002/dneu.2271231347291
   PubMed Web of Science ®Google Scholar
• Jain G, Stuendl A, Rao P, et al. A combined miRNA-piRNA signature to detect Alzheimer’s disease. Transl Psychiatry. 2019;9(1):250. doi:10.1038/s41398-019-0579-231591382
   PubMed Web of Science ®Google Scholar
• Yang L, Zhai Y, Hao Y, Zhu Z, Cheng G. The regulatory functionality of exosomes derived from hUMSCs in 3D culture for alzheimer’s disease therapy. Small. 2020;16(3):e1906273. doi:10.1002/smll.20190627331840420
   PubMed Web of Science ®Google Scholar
• Nakano M, Kubota K, Kobayashi E, et al. Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer’s disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep. 2020;10(1):10772. doi:10.1038/s41598-020-67460-132612165
   PubMed Web of Science ®Google Scholar
• Wang H, Sui H, Zheng Y, et al. Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK-3beta pathway. Nanoscale. 2019;11(15):7481–7496. doi:10.1039/C9NR01255A30942233
   PubMed Web of Science ®Google Scholar
• Qi Y, Guo L, Jiang Y, Shi Y, Sui H, Zhao L. Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles. Drug Deliv. 2020;27(1):745–755. doi:10.1080/10717544.2020.176226232397764
   PubMed Web of Science ®Google Scholar
• Hayashi N, Doi H, Kurata Y, et al. Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients. Neurosci Res. 2019;S0168–S0102(19):.30487
   Google Scholar
• Thompson AG, Gray E, Mager I, et al. CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis. Clin Proteomics. 2020;17:31. doi:10.1186/s12014-020-09294-732821252
   PubMed Web of Science ®Google Scholar
• Katsu M, Hama Y, Utsumi J, et al. MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis. Neurosci Lett. 2019;708:134176. doi:10.1016/j.neulet.2019.03.04831173847
   PubMed Web of Science ®Google Scholar
• Saucier D, Wajnberg G, Roy J, et al. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Res. 2019;1708:100–108. doi:10.1016/j.brainres.2018.12.01630552897
   PubMed Web of Science ®Google Scholar
• Lee M, Ban JJ, Kim KY, et al. Adipose-derived stem cell exosomes alleviate pathology of amyotrophic lateral sclerosis in vitro. Biochem Biophys Res Commun. 2016;479(3):434–439. doi:10.1016/j.bbrc.2016.09.06927641665
   PubMed Web of Science ®Google Scholar
• Bonafede R, Brandi J, Manfredi M, et al. The anti-apoptotic effect of ASC-exosomes in an in vitro ALS model and their proteomic analysis. Cells. 2019;8(9):1087. doi:10.3390/cells8091087
   Web of Science ®Google Scholar
• Bonafede R, Turano E, Scambi I, et al. ASC-exosomes ameliorate the disease progression in SOD1(G93A) murine model underlining their potential therapeutic use in human ALS. Int J Mol Sci. 2020;21(10):3651. doi:10.3390/ijms21103651
   Web of Science ®Google Scholar
• Wang G, Dinkins M, He Q, et al. Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem. 2012;287(25):21384–21395. doi:10.1074/jbc.M112.34051322532571
   PubMed Web of Science ®Google Scholar
• Ubhi K, Peng K, Lessig S, et al. Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease. Neurosci Lett. 2010;485(3):222–227. doi:10.1016/j.neulet.2010.09.01620849919
   PubMed Web of Science ®Google Scholar
• Colom-Cadena M, Grau-Rivera O, Planellas L, et al. Regional overlap of pathologies in lewy body disorders. J Neuropathol Exp Neurol. 2017;76(3):216–224. doi:10.1093/jnen/nlx00228395086
   PubMed Web of Science ®Google Scholar
• Gamez-Valero A, Campdelacreu J, Rene R, Beyer K, Borras FE. Comprehensive proteomic profiling of plasma-derived Extracellular Vesicles from dementia with Lewy Bodies patients. Sci Rep. 2019;9(1):13282. doi:10.1038/s41598-019-49668-y31527695
   PubMed Web of Science ®Google Scholar
• Gamez-Valero A, Campdelacreu J, Vilas D, et al. Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer’s disease and dementia with Lewy bodies. Transl Neurodegener. 2019;8:31. doi:10.1186/s40035-019-0169-531592314
   PubMed Web of Science ®Google Scholar
• Chen Y, Song Y, Huang J, et al. Increased circulating exosomal miRNA-223 is associated with acute ischemic stroke. Front Neurol. 2017;8:57. doi:10.3389/fneur.2017.0005728289400
   PubMed Web of Science ®Google Scholar
• Ji Q, Ji Y, Peng J, et al. Increased brain-specific MiR-9 and MiR-124 in the serum exosomes of acute ischemic stroke patients. PLoS One. 2016;11(9):e0163645. doi:10.1371/journal.pone.016364527661079
   PubMed Web of Science ®Google Scholar
• Kerr N, Garcia-Contreras M, Abbassi S, et al. Inflammasome proteins in serum and serum-derived extracellular vesicles as biomarkers of stroke. Front Mol Neurosci. 2018;11:309. doi:10.3389/fnmol.2018.0030930233311
   PubMed Web of Science ®Google Scholar
• Gui Y, Xu Z, Jin T, et al. Using extracellular circulating microRNAs to classify the etiological subtypes of ischemic stroke. Transl Stroke Res. 2019;10(4):352–361. doi:10.1007/s12975-018-0659-230178428
   PubMed Web of Science ®Google Scholar
• Kalani MYS, Alsop E, Meechoovet B, et al. Extracellular microRNAs in blood differentiate between ischaemic and haemorrhagic stroke subtypes. J Extracell Vesicles. 2020;9(1):1713540. doi:10.1080/20013078.2020.171354032128071
   PubMed Web of Science ®Google Scholar
• Chi NF, Chiou HY, Chou SY, et al. Hyperglycemia-related FAS gene and hsa-let-7b-5p as markers of poor outcomes for ischaemic stroke. Eur J Neurol. 2020;27(8):1647–1655. doi:10.1111/ene.1428832352616
   PubMed Web of Science ®Google Scholar
• Doeppner TR, Herz J, Gorgens A, et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4(10):1131–1143. doi:10.5966/sctm.2015-007826339036
   PubMed Web of Science ®Google Scholar
• Otero-Ortega L, Laso-Garcia F, Gomez-de Frutos MD, et al. White matter repair after extracellular vesicles administration in an experimental animal model of subcortical stroke. Sci Rep. 2017;7:44433. doi:10.1038/srep4443328300134
   PubMed Web of Science ®Google Scholar
• Moon GJ, Sung JH, Kim DH, et al. Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: biodistribution and MicroRNA Study. Transl Stroke Res. 2019;10(5):509–521. doi:10.1007/s12975-018-0668-130341718
   PubMed Web of Science ®Google Scholar
• Webb RL, Kaiser EE, Jurgielewicz BJ, et al. Human neural stem cell extracellular vesicles improve recovery in a porcine model of ischemic stroke. Stroke. 2018;49(5):1248–1256. doi:10.1161/STROKEAHA.117.02035329650593
   PubMed Web of Science ®Google Scholar
• Zheng X, Zhang L, Kuang Y, et al. Extracellular vesicles derived from neural progenitor cells–a preclinical evaluation for stroke treatment in mice. Transl Stroke Res. 2020;12:185–203. doi:10.1007/s12975-020-00814-z32361827
   PubMed Web of Science ®Google Scholar
• Lapchak PA, Boitano PD, de Couto G, Marban E. Intravenous xenogeneic human cardiosphere-derived cell extracellular vesicles (exosomes) improves behavioral function in small-clot embolized rabbits. Exp Neurol. 2018;307:109–117. doi:10.1016/j.expneurol.2018.06.00729908146
   PubMed Web of Science ®Google Scholar
• Yang J, Zhao Y, Zhang L, et al. RIPK3/MLKL-mediated neuronal necroptosis modulates the M1/M2 polarization of microglia/macrophages in the ischemic cortex. Cereb Cortex. 2018;28(7):2622–2635. doi:10.1093/cercor/bhy08929746630
   PubMed Web of Science ®Google Scholar
• Ghosh M, Xu Y, Pearse DD. Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines. J Neuroinflammation. 2016;13:9. doi:10.1186/s12974-015-0463-926757726
   PubMed Web of Science ®Google Scholar
• Brifault C, Gras M, Liot D, May V, Vaudry D, Wurtz O. Delayed pituitary adenylate cyclase-activating polypeptide delivery after brain stroke improves functional recovery by inducing m2 microglia/macrophage polarization. Stroke. 2015;46(2):520–528. doi:10.1161/STROKEAHA.114.00686425550371
   PubMed Web of Science ®Google Scholar
• Zheng Y, He R, Wang P, Shi Y, Zhao L, Liang J. Exosomes from LPS-stimulated macrophages induce neuroprotection and functional improvement after ischemic stroke by modulating microglial polarization. Biomater Sci. 2019;7(5):2037–2049. doi:10.1039/C8BM01449C30843911
   PubMed Web of Science ®Google Scholar
• Song Y, Li Z, He T, et al. M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124. Theranostics. 2019;9(10):2910–2923. doi:10.7150/thno.3087931244932
   PubMed Web of Science ®Google Scholar
• Tian T, Zhang HX, He CP, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137–149. doi:10.1016/j.biomaterials.2017.10.01229040874
   PubMed Web of Science ®Google Scholar
• Yang J, Wu S, Hou L, et al. Therapeutic effects of simultaneous delivery of nerve growth factor mRNA and protein via exosomes on cerebral ischemia. Mol Ther Nucleic Acids. 2020;21:512–522. doi:10.1016/j.omtn.2020.06.01332682291
   PubMedGoogle Scholar
• Li F, Zhao L, Shi Y, Liang J. Edaravone-loaded macrophage-derived exosomes enhance neuroprotection in the rat permanent middle cerebral artery occlusion model of stroke. Mol Pharm. 2020;17(9):3192–3201. doi:10.1021/acs.molpharmaceut.0c0024532786956
   PubMed Web of Science ®Google Scholar
• Xin H, Katakowski M, Wang F, et al. MicroRNA cluster miR-17-92 cluster in exosomes enhance neuroplasticity and functional recovery after stroke in rats. Stroke. 2017;48(3):747–753. doi:10.1161/STROKEAHA.116.01520428232590
   PubMed Web of Science ®Google Scholar
• Zhang H, Wu J, Wu J, et al. Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice. J Nanobiotechnology. 2019;17(1):29. doi:10.1186/s12951-019-0461-730782171
   PubMed Web of Science ®Google Scholar
• Venkat P, Cui C, Chopp M, et al. MiR-126 mediates brain endothelial cell exosome treatment-induced neurorestorative effects after stroke in type 2 diabetes mellitus mice. Stroke. 2019;50(10):2865–2874. doi:10.1161/STROKEAHA.119.02537131394992
   PubMed Web of Science ®Google Scholar
• Yang L, Han B, Zhang Z, et al. Extracellular vesicle-mediated delivery of circular RNA SCMH1 promotes functional recovery in rodent and nonhuman primate ischemic stroke models. Circulation. 2020;142(6):556–574. doi:10.1161/CIRCULATIONAHA.120.04576532441115
   PubMed Web of Science ®Google Scholar
• Mutch CA, Talbott JF, Gean A. Imaging evaluation of acute traumatic brain injury. Neurosurg Clin N Am. 2016;27(4):409–439. doi:10.1016/j.nec.2016.05.01127637393
   PubMed Web of Science ®Google Scholar
• Manek R, Moghieb A, Yang Z, et al. Protein biomarkers and neuroproteomics characterization of microvesicles/exosomes from human cerebrospinal fluid following traumatic brain injury. Mol Neurobiol. 2018;55(7):6112–6128. doi:10.1007/s12035-017-0821-y29188495
   PubMed Web of Science ®Google Scholar
• Cheng Y, Pereira M, Raukar N, et al. Potential biomarkers to detect traumatic brain injury by the profiling of salivary extracellular vesicles. J Cell Physiol. 2019;234(8):14377–14388. doi:10.1002/jcp.2813930644102
   PubMed Web of Science ®Google Scholar
• Wang P, Ma H, Zhang Y, et al. Plasma exosome-derived microRNAs as novel biomarkers of traumatic brain injury in rats. Int J Med Sci. 2020;17(4):437–448. doi:10.7150/ijms.3966732174774
   PubMed Web of Science ®Google Scholar
• Williams AM, Bhatti UF, Brown JF, et al. Early single-dose treatment with exosomes provides neuroprotection and improves blood-brain barrier integrity in swine model of traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg. 2020;88(2):207–218. doi:10.1097/TA.000000000000256331804413
   PubMed Web of Science ®Google Scholar
• Williams AM, Wu Z, Bhatti UF, et al. Early single-dose exosome treatment improves neurologic outcomes in a 7-day swine model of traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg. 2020;89(2):388–396. doi:10.1097/TA.000000000000269832218019
   PubMed Web of Science ®Google Scholar
• Kim DK, Nishida H, An SY, Shetty AK, Bartosh TJ, Prockop DJ. Chromatographically isolated CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI. Proc Natl Acad Sci U S A. 2016;113(1):170–175. doi:10.1073/pnas.152229711326699510
   PubMed Web of Science ®Google Scholar
• Ge X, Guo M, Hu T, et al. Increased microglial exosomal miR-124-3p alleviates neurodegeneration and improves cognitive outcome after rmTBI. Mol Ther. 2020;28(2):503–522. doi:10.1016/j.ymthe.2019.11.01731843449
   PubMed Web of Science ®Google Scholar
• Li Y, Yang YY, Ren JL, Xu F, Chen FM, Li A. Exosomes secreted by stem cells from human exfoliated deciduous teeth contribute to functional recovery after traumatic brain injury by shifting microglia M1/M2 polarization in rats. Stem Cell Res Ther. 2017;8(1):198. doi:10.1186/s13287-017-0648-528962585
   PubMed Web of Science ®Google Scholar
• Ding SQ, Chen YQ, Chen J, et al. Serum exosomal microRNA transcriptome profiling in subacute spinal cord injured rats. Genomics. 2020;112(2):2092–2105. doi:10.1016/j.ygeno.2019.12.00331830526
   PubMed Web of Science ®Google Scholar
• Romanelli P, Bieler L, Scharler C, et al. Extracellular vesicles can deliver anti-inflammatory and anti-scarring activities of mesenchymal stromal cells after spinal cord injury. Front Neurol. 2019;10:1225. doi:10.3389/fneur.2019.0122531849808
   PubMed Web of Science ®Google Scholar
• Goncalves MB, Malmqvist T, Clarke E, et al. Neuronal RARbeta signaling modulates PTEN activity directly in neurons and via exosome transfer in astrocytes to prevent glial scar formation and induce spinal cord regeneration. J Neurosci. 2015;35(47):15731–15745. doi:10.1523/JNEUROSCI.1339-15.201526609164
   PubMed Web of Science ®Google Scholar
• Guo S, Perets N, Betzer O, et al. Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog siRNA repairs complete spinal cord injury. ACS Nano. 2019;13(9):10015–10028. doi:10.1021/acsnano.9b0189231454225
   PubMed Web of Science ®Google Scholar
• Wang Z, Song Y, Han X, Qu P, Wang W. Long noncoding RNA PTENP1 affects the recovery of spinal cord injury by regulating the expression of miR-19b and miR-21. J Cell Physiol. 2020;235(4):3634–3645. doi:10.1002/jcp.2925331583718
   PubMed Web of Science ®Google Scholar
• Kang J, Li Z, Zhi Z, Wang S, Xu G. MiR-21 derived from the exosomes of MSCs regulates the death and differentiation of neurons in patients with spinal cord injury. Gene Ther. 2019;26(12):491–503. doi:10.1038/s41434-019-0101-831570818
   PubMed Web of Science ®Google Scholar
• Xu G, Ao R, Zhi Z, Jia J, Yu B. miR-21 and miR-19b delivered by hMSC-derived EVs regulate the apoptosis and differentiation of neurons in patients with spinal cord injury. J Cell Physiol. 2019;234(7):10205–10217. doi:10.1002/jcp.2769030387159
   PubMed Web of Science ®Google Scholar
• He J, Ren M, Li H, Yang L, Wang X, Yang Q. Exosomal circular RNA as a biomarker platform for the early diagnosis of immune-mediated demyelinating disease. Front Genet. 2019;10:860. doi:10.3389/fgene.2019.0086031611906
   PubMed Web of Science ®Google Scholar
• Kutzelnigg A, Lassmann H. Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handb Clin Neurol. 2014;122:15–58.24507512
   PubMedGoogle Scholar
• Ebrahimkhani S, Vafaee F, Young PE, et al. Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci Rep. 2017;7(1):14293. doi:10.1038/s41598-017-14301-329084979
   PubMed Web of Science ®Google Scholar
• Selmaj I, Cichalewska M, Namiecinska M, et al. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol. 2017;81(5):703–717. doi:10.1002/ana.2493128411393
   PubMed Web of Science ®Google Scholar
• Manna I, Iaccino E, Dattilo V, et al. Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients. FASEB J. 2018;32(8):4241–4246. doi:10.1096/fj.201701533R29505299
   PubMed Web of Science ®Google Scholar
• Ebrahimkhani S, Beadnall HN, Wang C, et al. Serum exosome microRNAs predict multiple sclerosis disease activity after fingolimod treatment. Mol Neurobiol. 2020;57(2):1245–1258. doi:10.1007/s12035-019-01792-631721043
   PubMed Web of Science ®Google Scholar
• Chen C, Wu Y, Li M, et al. Different exosomal microRNA profile in aquaporin-4 antibody positive neuromyelitis optica spectrum disorders. Front Immunol. 2020;11:1064. doi:10.3389/fimmu.2020.0106432547558
   PubMed Web of Science ®Google Scholar
• Casella G, Colombo F, Finardi A, et al. Extracellular vesicles containing IL-4 modulate neuroinflammation in a mouse model of multiple sclerosis. Mol Ther. 2018;26(9):2107–2118. doi:10.1016/j.ymthe.2018.06.02430017878
   PubMed Web of Science ®Google Scholar
• Clark K, Zhang S, Barthe S, et al. Placental mesenchymal stem cell-derived extracellular vesicles promote myelin regeneration in an animal model of multiple sclerosis. Cells. 2019;8(12):1497. doi:10.3390/cells8121497
   Web of Science ®Google Scholar
• Hosseini Shamili F, Alibolandi M, Rafatpanah H, et al. Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score. J Control Release. 2019;299:149–164. doi:10.1016/j.jconrel.2019.02.03230807806
   PubMed Web of Science ®Google Scholar
• Hyun KA, Kim J, Gwak H, Jung HI. Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics. Analyst. 2016;141(2):382–392. doi:10.1039/C5AN01762A26588824
   PubMed Web of Science ®Google Scholar
• Figueroa JM, Skog J, Akers J, et al. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients. Neuro Oncol. 2017;19(11):1494–1502. doi:10.1093/neuonc/nox08528453784
   PubMed Web of Science ®Google Scholar
• Akers JC, Ramakrishnan V, Kim R, et al. miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients. J Neurooncol. 2015;123(2):205–216. doi:10.1007/s11060-015-1784-325903655
   PubMed Web of Science ®Google Scholar
• Lan F, Qing Q, Pan Q, Hu M, Yu H, Yue X. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma. Cell Oncol (Dordr). 2018;41(1):25–33. doi:10.1007/s13402-017-0355-329076027
   PubMed Web of Science ®Google Scholar
• Ricklefs FL, Maire CL, Matschke J, et al. FASN is a biomarker enriched in malignant glioma-derived extracellular vesicles. Int J Mol Sci. 2020;21(6):1931. doi:10.3390/ijms21061931
   Web of Science ®Google Scholar
• Garcia-Romero N, Carrion-Navarro J, Esteban-Rubio S, et al. DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients. Oncotarget. 2017;8(1):1416–1428. doi:10.18632/oncotarget.1363527902458
   PubMedGoogle Scholar
• Indira Chandran V, Welinder C, Mansson AS, et al. Ultrasensitive immunoprofiling of plasma extracellular vesicles identifies syndecan-1 as a potential tool for minimally invasive diagnosis of glioma. Clin Cancer Res. 2019;25(10):3115–3127.30679164
   PubMed Web of Science ®Google Scholar
• Melki I, Tessandier N, Zufferey A, Boilard E. Platelet microvesicles in health and disease. Platelets. 2017;28(3):214–221. doi:10.1080/09537104.2016.126592428102737
   PubMed Web of Science ®Google Scholar
• Al-Mufti F, Claassen J. Neurocritical care: status epilepticus review. Crit Care Clin. 2014;30(4):751–764. doi:10.1016/j.ccc.2014.06.00625257739
   PubMed Web of Science ®Google Scholar
• Raoof R, Jimenez-Mateos EM, Bauer S, et al. Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus. Sci Rep. 2017;7(1):3328. doi:10.1038/s41598-017-02969-628607431
   PubMed Web of Science ®Google Scholar
• Yan S, Zhang H, Xie W, et al. Altered microRNA profiles in plasma exosomes from mesial temporal lobe epilepsy with hippocampal sclerosis. Oncotarget. 2017;8(3):4136–4146. doi:10.18632/oncotarget.1374427926529
   PubMedGoogle Scholar
• Lin Z, Gu Y, Zhou R, et al. Serum exosomal proteins F9 and TSP-1 as potential diagnostic biomarkers for newly diagnosed epilepsy. Front Neurosci. 2020;14:737. doi:10.3389/fnins.2020.0073732848539
   PubMed Web of Science ®Google Scholar
• Upadhya D, Shetty AK. Promise of extracellular vesicles for diagnosis and treatment of epilepsy. Epilepsy Behav. 2019;106499. doi:10.1016/j.yebeh.2019.10649931636006
   PubMed Web of Science ®Google Scholar
• Costa-Ferro ZS, Souza BS, Leal MM, et al. Transplantation of bone marrow mononuclear cells decreases seizure incidence, mitigates neuronal loss and modulates pro-inflammatory cytokine production in epileptic rats. Neurobiol Dis. 2012;46(2):302–313. doi:10.1016/j.nbd.2011.12.00122198377
   PubMed Web of Science ®Google Scholar
• Long Q, Upadhya D, Hattiangady B, et al. Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus. Proc Natl Acad Sci U S A. 2017;114(17):E3536–E3545. doi:10.1073/pnas.170392011428396435
   PubMed Web of Science ®Google Scholar
• Cao XY, Lu JM, Zhao ZQ, et al. MicroRNA biomarkers of Parkinson’s disease in serum exosome-like microvesicles. Neurosci Lett. 2017;644:94–99. doi:10.1016/j.neulet.2017.02.04528223160
   PubMed Web of Science ®Google Scholar
• Yao YF, Qu MW, Li GC, Zhang FB, Rui HC. Circulating exosomal miRNAs as diagnostic biomarkers in Parkinson’s disease. Eur Rev Med Pharmacol Sci. 2018;22(16):5278–5283. doi:10.26355/eurrev_201808_1572730178852
   PubMed Web of Science ®Google Scholar
• Barbagallo C, Mostile G, Baglieri G, et al. Specific signatures of serum miRNAs as potential biomarkers to discriminate clinically similar neurodegenerative and vascular-related diseases. Cell Mol Neurobiol. 2020;40(4):531–546. doi:10.1007/s10571-019-00751-y31691877
   PubMed Web of Science ®Google Scholar